(Q51720557)

10 April 2018

title

Severe pneumonia and a second antibiotic. (English)

1 reference

10 April 2018

0 references

John Macfarlane

1

1 reference

10 April 2018

language of work or name

English

0 references

publication date

1 April 2002

1 reference

10 April 2018

published in

The Lancet

1 reference

10 April 2018

volume

359

1 reference

10 April 2018

issue

9313

1 reference

10 April 2018

page(s)

1170-1172

1 reference

10 April 2018

Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908250-8

7 January 2021

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908250-8

7 January 2021

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908250-8

7 January 2021

The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908250-8

7 January 2021

Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908250-8

7 January 2021

Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908250-8

7 January 2021

Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908250-8

7 January 2021

Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908250-8

7 January 2021

Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908250-8

7 January 2021

Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908250-8

7 January 2021

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908250-8

7 January 2021

10.1016/S0140-6736(02)08250-8

Identifiers

DOI

1 reference

10 April 2018

1 reference

10 April 2018